PDF(Pubmed)
Abstract：
UNASSIGNED: To investigate the safety and outcomes of endovascular embolization and craniotomy clipping in the treatment of cerebral aneurysms.
UNASSIGNED: We collected the clinical data of 106 patients with cerebral aneurysm who underwent surgical treatment (endovascular embolization, Group-A, n=55; craniotomy clipping, Group-B, n=51) in the First People\'s Hospital of Yichang from January 2020 to May 2021. We compared surgical treatment indexes, treatment costs, neurological function before and after the treatment, incidence of postoperative complications and the prognosis after one-year follow-up between the two groups.
UNASSIGNED: Endovascular embolization (Group-A) was associated with a shorter mean operation time and hospital stay, a lower mean intraoperative bleeding amount, and a higher mean treatment cost than craniotomy clipping (Group-B) (P<0.05). Compared with the pre-operative neurological function scores, the scores of both groups decreased after the surgery, and the mean post-operative score of Group-A was significantly lower than that of Group-B (P<0.05). Compared with Group-B , patients in Group-A had a lower overall complication rate (P < 0.05. Higher proportion of patients in Group-A had a good prognosis (P < 0.05).
UNASSIGNED: Endovascular embolization for the treatment of cerebral aneurysms is safe as it can shorten the operation time and hospital stay, reduce the incidence of neurological injury and complications, and have a favorable prognosis. However, the treatment is more expensive. Endovascular embolization can be selected for the treatment of cerebral aneurysms when economic conditions allow it.
UNASSIGNED: We collected the clinical data of 106 patients with cerebral aneurysm who underwent surgical treatment (endovascular embolization, Group-A, n=55; craniotomy clipping, Group-B, n=51) in the First People\'s Hospital of Yichang from January 2020 to May 2021. We compared surgical treatment indexes, treatment costs, neurological function before and after the treatment, incidence of postoperative complications and the prognosis after one-year follow-up between the two groups.
UNASSIGNED: Endovascular embolization (Group-A) was associated with a shorter mean operation time and hospital stay, a lower mean intraoperative bleeding amount, and a higher mean treatment cost than craniotomy clipping (Group-B) (P<0.05). Compared with the pre-operative neurological function scores, the scores of both groups decreased after the surgery, and the mean post-operative score of Group-A was significantly lower than that of Group-B (P<0.05). Compared with Group-B , patients in Group-A had a lower overall complication rate (P < 0.05. Higher proportion of patients in Group-A had a good prognosis (P < 0.05).
UNASSIGNED: Endovascular embolization for the treatment of cerebral aneurysms is safe as it can shorten the operation time and hospital stay, reduce the incidence of neurological injury and complications, and have a favorable prognosis. However, the treatment is more expensive. Endovascular embolization can be selected for the treatment of cerebral aneurysms when economic conditions allow it.
摘要：
■探讨血管内栓塞和开颅手术夹闭治疗脑动脉瘤的安全性和结果。
■我们收集了106例接受手术治疗的脑动脉瘤患者的临床资料（血管内栓塞，A组,n=55；开颅手术夹闭，B组,n=51），于2020年1月至2021年5月在宜昌市第一人民医院就诊。我们比较了手术治疗指标，治疗费用，治疗前后的神经功能，术后并发症发生率及随访1年后的预后情况。
■血管内栓塞（A组）与较短的平均手术时间和住院时间有关，术中平均出血量较低，平均治疗费用高于开颅夹闭（B组）（P<0.05）。与术前神经功能评分比较,两组患者术后评分均下降,A组术后平均评分明显低于B组(P<0.05)。与B组相比，A组患者的总体并发症发生率较低（P<0.05。A组患者预后良好的比例较高(P<0.05)。
■血管内栓塞治疗脑动脉瘤是安全的，因为它可以缩短手术时间和住院时间，减少神经损伤和并发症的发生率，预后良好.然而,治疗费用更高。当经济条件允许时，可以选择血管内栓塞来治疗脑动脉瘤。
■我们收集了106例接受手术治疗的脑动脉瘤患者的临床资料（血管内栓塞，A组,n=55；开颅手术夹闭，B组,n=51），于2020年1月至2021年5月在宜昌市第一人民医院就诊。我们比较了手术治疗指标，治疗费用，治疗前后的神经功能，术后并发症发生率及随访1年后的预后情况。
■血管内栓塞（A组）与较短的平均手术时间和住院时间有关，术中平均出血量较低，平均治疗费用高于开颅夹闭（B组）（P<0.05）。与术前神经功能评分比较,两组患者术后评分均下降,A组术后平均评分明显低于B组(P<0.05)。与B组相比，A组患者的总体并发症发生率较低（P<0.05。A组患者预后良好的比例较高(P<0.05)。
■血管内栓塞治疗脑动脉瘤是安全的，因为它可以缩短手术时间和住院时间，减少神经损伤和并发症的发生率，预后良好.然而,治疗费用更高。当经济条件允许时，可以选择血管内栓塞来治疗脑动脉瘤。
